Craig Hackett
Impact in
-
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Oncology top 10%
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
Papers in
-
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 2
- Viral Infectious Diseases and Gene Expression in Insects 1
-
- Cancer Mechanisms and Therapy 1
- Systemic Sclerosis and Related Diseases 1
- Spinal Cord Injury Research 1
- Co-authors
- Ferenc Boldog (5 shared papers)Henri S. Lichenstein (4 shared papers)Michael Jeffers (2 shared papers)Maxwell Sehested (2 shared papers)Peter Buhl Jensen (2 shared papers)Paul W. Finn (2 shared papers)Xiaozhong Qian (1 shared paper)Nagma Khan (1 shared paper)
- Journals
- International Immunology (1 paper)Clinical Cancer Research (1 paper)Blood (1 paper)Cancer Biology & Therapy (1 paper)The Lancet Neurology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Craig Hackett
11 papers receiving 948 citations
Craig Hackett's Hit Papers
Peers
Comparison fields: 5 of 86
- Molecular Biology 664
- Oncology 222
- Physiology 30
- Cellular and Molecular Neuroscience 96
- Immunology 88
Countries citing papers authored by Craig Hackett
This map shows the geographic impact of Craig Hackett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Hackett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Hackett more than expected).
Fields of papers citing papers by Craig Hackett
This network shows the impact of papers produced by Craig Hackett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Hackett. The network helps show where Craig Hackett may publish in the future.
Co-authors
The 25 scholars most cited alongside Craig Hackett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors Hit paper breakdown → | 2007 | 619 |
| 2 | 2006 | 148 | |
| 3 | 2005 | 65 | |
| 4 | 1991 | 48 | |
| 5 | 2023 | 33 | |
| 6 | 2006 | 20 | |
| 7 | 2002 | 17 | |
| 8 | 2016 | 11 | |
| 9 | 2016 | 7 | |
| 10 | 2025 | 1 | |
| 11 | 2006 | 1 |
About Craig Hackett
Craig Hackett is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Public Health, Environmental and Occupational Health and Immunology, having authored 11 papers that have together received 970 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer Mechanisms and Therapy (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Systemic Sclerosis and Related Diseases (1 paper), Galectins and Cancer Biology (1 paper), Immunotherapy and Immune Responses (1 paper) and Spinal Cord Injury Research (1 paper). The work is most often cited by research in Molecular Biology (664 citations), Oncology (222 citations), Physiology (30 citations), Cellular and Molecular Neuroscience (96 citations) and Immunology (88 citations). Craig Hackett has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Ferenc Boldog, Henri S. Lichenstein, Michael Jeffers, Maxwell Sehested, Peter Buhl Jensen, Paul W. Finn, Xiaozhong Qian, Nagma Khan, Nessa Carey and James W.A. Ritchie. Their work appears in journals such as International Immunology, Clinical Cancer Research, Blood, Cancer Biology & Therapy and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.